Topotecan

FDA Approved: * February 2, 2011
Pharm Company: * HOSPIRA
Category: Cancer

Topotecan, sold under the brand name Hycamtin among others, is a chemotherapeutic agent medication that is a topoisomerase inhibitor. It is a synthetic, water-soluble analog of the natural chemical compound camptothecin. It is used in the form of its hydrochloride salt to treat ovarian cancer, lung cancer and other cancer types. After GlaxoSmithKline received final FDA approval for topotecan on October 15, 2007, it became the first topoisomerase I inhibitor for oral use.[citation nee... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Topotecan Hydrochloride 4 mg/4ml Intravenous Injection, Powder, Lyophilized, for Solution
NDC: 0069-0075
Labeler:
Pfizer Laboratories Div Pfizer Inc.
Topotecan 1 mg/ml Intravenous Injection, Solution, Concentrate
NDC: 0409-0302
Labeler:
Hospira, Inc.
Topotecan 1 mg/ml Intravenous Injection, Solution, Concentrate
NDC: 0703-4714
Labeler:
Teva Parenteral Medicines, Inc.
Topotecan Hydrochloride 4 mg/4ml Intravenous Injection, Powder, Lyophilized, for Solution
NDC: 16729-151
Labeler:
Accord Healthcare Inc.
Topotecan 1 mg/ml Intravenous Injection
NDC: 16729-243
Labeler:
Accord Healthcare Inc.
Topotecan Hydrochloride 4 mg/4ml Intravenous Injection, Powder, Lyophilized, for Solution
NDC: 25021-206
Labeler:
Sagent Pharmaceuticals
Topotecan 1 mg/ml Intravenous Injection, Solution, Concentrate
NDC: 25021-236
Labeler:
Sagent Pharmaceuticals
Topotecan Hydrochloride 4 mg/4ml Intravenous Injection, Powder, Lyophilized, for Solution
NDC: 25021-824
Labeler:
Sagent Pharmaceuticals
Topotecan Hydrochloride 4 mg/4ml Intravenous Injection, Powder, Lyophilized, for Solution
NDC: 45963-615
Labeler:
Actavis Pharma, Inc.
Topotecan 4 mg/4ml Intravenous Injection, Powder, Lyophilized, for Solution
NDC: 50742-404
Labeler:
Ingenus Pharmaceuticals, LLC

Related Brands

Drugs with the same active ingredients